|
|
|
Volumn 9, Issue 2, 2008, Pages 128-131
|
|
2007: A difficult year for HCV drug development
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANA 598;
ANA 975;
CILUPREVIR;
GENELAB;
ITMN 191;
MK 3281;
MK 7009;
PEGINTERFERON;
PF 868554;
R 7227;
RIBAVIRIN;
TELAPREVIR;
TMC 435350;
UNCLASSIFIED DRUG;
CELL CULTURE;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG STRUCTURE;
EDITORIAL;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
LIVER TRANSPLANTATION;
TREATMENT DURATION;
VIROTHERAPY;
VIRUS INFECTION;
VIRUS REPLICATION;
VIRUS TRANSMISSION;
ANTIVIRAL AGENTS;
CARRIER PROTEINS;
CLINICAL TRIALS AS TOPIC;
DRUG THERAPY;
DRUG THERAPY, COMBINATION;
ENZYME INHIBITORS;
HEPATITIS C;
HUMANS;
NUCLEIC ACID SYNTHESIS INHIBITORS;
SERINE PROTEINASE INHIBITORS;
VIRAL NONSTRUCTURAL PROTEINS;
VIRAL PROTEINS;
|
|
EID: 38849168927
PISSN: 14724472
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (9)
|
|
References (0)
|
